194 related articles for article (PubMed ID: 31556779)
1. Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer.
Anttinen M; Mäkelä P; Suomi V; Kiviniemi A; Saunavaara J; Sainio T; Horte A; Eklund L; Taimen P; Sequeiros RB; Boström PJ
Scand J Urol; 2019 Oct; 53(5):295-302. PubMed ID: 31556779
[No Abstract] [Full Text] [Related]
2. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
3. Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
Nair SM; Stern N; Dewar M; Siddiqui K; Smith E; Gomez JA; Moussa M; Chin JL
Scand J Urol; 2020 Jun; 54(3):215-219. PubMed ID: 32308085
[No Abstract] [Full Text] [Related]
4. Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer.
Mäkelä P; Anttinen M; Suomi V; Steiner A; Saunavaara J; Sainio T; Horte A; Taimen P; Boström P; Blanco Sequeiros R
Acta Radiol; 2021 Dec; 62(12):1687-1695. PubMed ID: 33251811
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
[TBL] [Abstract][Full Text] [Related]
6. Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostate.
Bonekamp D; Wolf MB; Roethke MC; Pahernik S; Hadaschik BA; Hatiboglu G; Kuru TH; Popeneciu IV; Chin JL; Billia M; Relle J; Hafron J; Nandalur KR; Staruch RM; Burtnyk M; Hohenfellner M; Schlemmer HP
Eur Radiol; 2019 Jan; 29(1):299-308. PubMed ID: 29943185
[TBL] [Abstract][Full Text] [Related]
7. Histopathological evaluation of prostate specimens after thermal ablation may be confounded by the presence of thermally-fixed cells.
Anttinen M; Yli-Pietilä E; Suomi V; Mäkelä P; Sainio T; Saunavaara J; Eklund L; Blanco Sequeiros R; Taimen P; Boström PJ
Int J Hyperthermia; 2019; 36(1):915-925. PubMed ID: 31466481
[No Abstract] [Full Text] [Related]
8. Evaluation of Focal Ablation of Magnetic Resonance Imaging Defined Prostate Cancer Using Magnetic Resonance Imaging Controlled Transurethral Ultrasound Therapy with Prostatectomy as the Reference Standard.
Ramsay E; Mougenot C; Staruch R; Boyes A; Kazem M; Bronskill M; Foster H; Sugar L; Haider M; Klotz L; Chopra R
J Urol; 2017 Jan; 197(1):255-261. PubMed ID: 27545572
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study.
Nair SM; Hatiboglu G; Relle J; Hetou K; Hafron J; Harle C; Kassam Z; Staruch R; Burtnyk M; Bonekamp D; Schlemmer HP; Roethke MC; Mueller-Wolf M; Pahernik S; Chin JL
BJU Int; 2021 May; 127(5):544-552. PubMed ID: 33037765
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: single-center evaluation of 6-month treatment safety and functional outcomes of intensified treatment parameters.
Hatiboglu G; Popeneciu V; Bonekamp D; Burtnyk M; Staruch R; Pahernik S; Tosev G; Radtke JP; Motsch J; Schlemmer HP; Hohenfellner M; Nyarangi-Dix JN
World J Urol; 2020 Feb; 38(2):343-350. PubMed ID: 31062122
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer: A Systematic Review.
Dora C; Clarke GM; Frey G; Sella D
J Endourol; 2022 Jun; 36(6):841-854. PubMed ID: 35029127
[No Abstract] [Full Text] [Related]
12. Single center retrospective analysis of fifty-two prostate cancer patients with customized MR-guided transurethral ultrasound ablation (TULSA).
Lumiani A; Samun D; Sroka R; Muschter R
Urol Oncol; 2021 Dec; 39(12):830.e9-830.e16. PubMed ID: 34144892
[TBL] [Abstract][Full Text] [Related]
13. First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study.
Peters I; Hensen B; Glandorf J; Gutberlet M; Dohna M; Struckmann S; Kuczyk MA; Wacker F; Hellms S
BMC Urol; 2023 Aug; 23(1):142. PubMed ID: 37644453
[TBL] [Abstract][Full Text] [Related]
14. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12-month clinical outcomes of a phase I study.
Viitala A; Anttinen M; Wright C; Virtanen I; Mäkelä P; Hovinen T; Sainio T; Saunavaara J; Taimen P; Blanco Sequeiros R; Boström PJ
BJU Int; 2022 Feb; 129(2):208-216. PubMed ID: 34161649
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance image guided transurethral ultrasound prostate ablation: a preclinical safety and feasibility study with 28-day followup.
Burtnyk M; Hill T; Cadieux-Pitre H; Welch I
J Urol; 2015 May; 193(5):1669-75. PubMed ID: 25464003
[TBL] [Abstract][Full Text] [Related]
17. Tandem-robot assisted laparoscopic radical prostatectomy to improve the neurovascular bundle visualization: a feasibility study.
Han M; Kim C; Mozer P; Schäfer F; Badaan S; Vigaru B; Tseng K; Petrisor D; Trock B; Stoianovici D
Urology; 2011 Feb; 77(2):502-6. PubMed ID: 21067797
[TBL] [Abstract][Full Text] [Related]
18. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
[TBL] [Abstract][Full Text] [Related]
19. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
Natarajan S; Raman S; Priester AM; Garritano J; Margolis DJ; Lieu P; Macairan ML; Huang J; Grundfest W; Marks LS
J Urol; 2016 Jul; 196(1):68-75. PubMed ID: 26748164
[TBL] [Abstract][Full Text] [Related]
20. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy.
Lindner U; Lawrentschuk N; Weersink RA; Davidson SR; Raz O; Hlasny E; Langer DL; Gertner MR; Van der Kwast T; Haider MA; Trachtenberg J
Eur Urol; 2010 Jun; 57(6):1111-4. PubMed ID: 20346578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]